Aurobindo Pharma Ltd. - Research Center
524804 AUROPHARMA Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Dec' 24 |
Sep' 24 |
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sales |
2,916.63 |
2,824.59 |
2,460.09 |
2,894.03 |
2,692.03 |
Operating profit |
713.15 |
720.88 |
498.93 |
774.79 |
481.69 |
Interest |
66.19 |
51.63 |
51.13 |
53.07 |
61.25 |
Gross profit |
701.22 |
791.91 |
513.12 |
844.69 |
751.57 |
EPS (Rs) |
8.13 |
9.25 |
5.62 |
9.88 |
10.65 |
Quarterly
results in details
|
Dec' 24 |
Sep' 24 |
Jun' 24 |
Mar' 24 |
Dec' 23 |
Other income |
54.26 |
122.66 |
65.32 |
122.97 |
331.13 |
Stock adjustment |
-61.37 |
-31.25 |
-35.56 |
-13.10 |
-59.76 |
Raw material |
1,506.59 |
1,424.74 |
1,318.18 |
1,401.56 |
1,465.93 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
265.15 |
265.48 |
259.33 |
248.91 |
248.08 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
493.11 |
444.74 |
419.21 |
481.87 |
556.09 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
68.28 |
68.16 |
66.88 |
64.81 |
64.35 |
Taxation |
160.89 |
186.22 |
117.20 |
201.21 |
63.44 |
Net profit / loss |
472.05 |
537.53 |
329.04 |
578.67 |
623.78 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
58.08 |
58.08 |
58.59 |
58.59 |
58.59 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
24.45 |
25.52 |
20.28 |
26.77 |
17.89 |
GPM (%) |
23.60 |
26.87 |
20.32 |
28.00 |
24.86 |
NPM (%) |
15.89 |
18.24 |
13.03 |
19.18 |
20.63 |